Trials / Unknown
UnknownNCT05669872
Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer
A Prospective Randomized Controlled Trial Evaluating the Safety and Efficacy of Patient Blood Management Program in Patients With Gynecologic Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 334 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the safety and effectiveness of a patient blood management program in gynecological cancer patients
Detailed description
To demonstrate the safety and effectiveness of a patient blood management program in gynecological cancer patients undergoing surgery, radiation therapy, and chemotherapy, and to establish a patient blood management program and introduce it as a standard treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric Carboxymaltose 50Mg/Ml Inj 20Ml | ferric carboxymaltose 1000mg, fixed dose for intervention group |
| DRUG | RBC | pack RBC transfusion |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
- First posted
- 2023-01-03
- Last updated
- 2023-01-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05669872. Inclusion in this directory is not an endorsement.